Amanda I Adler
@DrAmandaAdler
Followers
1K
Following
2K
Media
36
Statuses
457
Physician; Professor Diabetic Medicine + Health Policy; NICE; WHO Technical Advisory Group Diabetes
Oxford, Cambridge, London
Joined May 2017
The ‘absorbing’ health state in Markov modelling. Sign from Sutton Hoo, Suffolk.
5
11
101
📣 Big news! We’re excited to announce the Advisory Board for The #LancetSummit: shaping the future of #diabetes prevention. Welcome @DrAmandaAdler, @kamleshkhunti, @DiannaMagliano, Chantal Mathieu and Didac Mauricio Puente. Submit your abstract to join: https://t.co/fpmvhqPUae
2
12
36
Gabriel Rogers presented #REDDIE project at the recent NICE HTA Lab Workshop on Novel types of data - Synthetic Data! He shared insights on how synthetic and real-world data can drive better, fairer HTA decision-making in diabetes and beyond. #SyntheticData #HTA
0
1
0
A great example of the importance of MAMS platform trials to test many therapies within the same trial. Metformin was arm K (!). “Metformin for patients with metastatic prostate cancer starting androg... https://t.co/nEzGpeh4Ub
@MRCCTU
0
0
3
Very much looking forward to supporting publicly funded research that informs important unanswered questions 💐
Congratulations to Professor @DrAmandaAdler, Professor of Diabetic Medicine and Health Policy at the Radcliffe Department of Medicine, @UniofOxford on her new appointment as the Chair of the Clinical Evaluation and Trials funding committee for our Health Technology Assessment
19
1
51
Great group of students- lotsa fun!
The Robert Turner #Course is underway at @KebleOxford . Led by top experts incl. @atsapas , Anne Clark, Fiona Gribble & @DrAmandaAdler, early career #researchers dive into #clinical research, evidence appraisal & stats. A unique chance to grow in a rich, collaborative setting!
0
0
6
We just hosted the second progress meeting of the Horizon Europe @REDDIE_Diabetes project at our department! Two days of discussions, workshops, and collaboration with our international partners—plus great food and spring vibes in Padua! 😊 #HorizonEurope #REDDIEDiabetes #UniPD
0
5
8
Now data on metformin benefits and hearing loss! Metformin use is associated with a dose-dependent reduction in hearing loss risk and lower mortality in people with T2 diabetes! Metformin keep giving! https://t.co/hZm0Ktdvb6
4
27
94
Still time to discuss/ apply for this clinical trials PhD opportunity in Glasgow!
📢Fully Funded PhD Project at University of Glasgow: We're excited to share these exciting opportunities funded by our @MRCTMRPDTP. For more information on this one see: https://t.co/InhZytiiK9
0
4
9
Impressive goings-on in HTA in Asia presented at an impressively organized meeting. A model for meetings on modelling. @HERC_Oxford @CUHKMedicine @HITAP_Thailand @RDMOxford
.@CUHKMedicine & @UniofOxford organised the “Mount Hood #Diabetes Health Economics Conference in Clinical Decision Making 2024” on Nov 23-24, to foster international collaborations and promote cost-effective decision-making to make #healthcare #sustainable. #MountHood2024
0
2
3
Just dropped - target trial emulation study on nationwide Scottish data showing better outcomes in patients who continued metformin after reaching CKD stage 4 - by @SamiraBell76 et al. Am J Kidney Disease https://t.co/36V4GFCDH7
0
9
22
For some treatments, NICE assesses effectiveness with ‘cure models’. Do ‘double cures’ offer twice the value? @NRLatimer @DrMeganJohn
0
1
8
Today´s afternoon movie is "Coco" /2017/ The concept for Coco is inspired by the Mexican holiday Day of the Dead.
1
2
11
People with 'young-onset' (antibody negative) type 2 diabetes have higher rates of complications including dying when attaining the same age as people diagnosed later; a call to further the evidence for preventing or delaying type 2 diabetes in young people.
Further data sets confirming importance of targeting 'Young Onset #T2Diabetes'- via the UKPDS @DrAmandaAdler et al Take time to look at work done by @ShivaniM_KC -architect of T2Day work from @NHSDiabetesProg to have focus on this area- with investments https://t.co/zYnOGSTgZr
1
5
21
NEW RESEARCH: Under-40s diagnosed with type 2 diabetes have a mortality rate four times higher than the general population Read more 👇 https://t.co/LhRm7XLCKy
@DrAmandaAdler @OxfordMedSci #researchnews #diabetesnews
0
4
4
New @LSHTM_GHECO + @Basucally + @DrAmandaAdler + @karlado paper on @HECJournalTweet! We used target trial emulation with local #IVs to examine treatment effect heterogeneity across subpopulations eligible and ineligible for a published RCT https://t.co/udjoOURUfz
1
7
36
Metformin in prostate cancer in a controlled trial with overall survival as the endpoint, and with metabolic secondary endpoints.
Second #Stampede presentation today @Silke_Gillessen on metformin in M1HSPC. Borderline OS gain, ?more in HV disease. Significant metabolic gains all pts @MRCCTU @ICR_London
0
2
15
Missed our first #REDDIE webinar on synthetic data for regulatory and payer purposes? Read about it in the article and watch the full session from the keynote speaker, Prof. Gillian Raab. 👇 https://t.co/YRgH0Z5Wfi
#SyntheticData #Webinar #RWD #HorizonEU
0
4
6
Finally! 4 years after scientific fraud & politicised science derailed it, #COPCOV, the world’s largest COVID-19 chemoprevention study, published results today in @PLOSMedicine: Hydroxychloroquine (HCQ) does have a moderate benefit in preventing #COVID-19 https://t.co/NJS3HtiUZY
0
14
15